FSH Test: When to Order It, What Your Results Mean, and What Comes Next

What Is FSH and Why Does It Matter for Women?

FSH is a glycoprotein hormone made in the anterior pituitary gland. It travels through the bloodstream to the ovaries, where it recruits a cohort of follicles each month and pushes them to grow and produce estradiol. No other single lab marker gives you as direct a window into the conversation between your brain and your ovaries.

For women, FSH is far more clinically meaningful than it is for men. Your FSH rises and falls across the menstrual cycle, shifts dramatically across decades, and changes abruptly during perimenopause. Understanding those patterns is why your clinician should interpret your FSH number alongside the date of your last period, your cycle day, and your age, not as a standalone value.

How FSH Changes Across the Menstrual Cycle

FSH starts rising in the late luteal phase of the previous cycle, peaks briefly around ovulation (the mid-cycle FSH surge accompanies the LH surge), then falls sharply in the luteal phase. Because of this variation, a blood draw on cycle day 2 or 3 captures the early-follicular baseline, which is the most reproducible and clinically interpretable result for fertility assessment. Drawing FSH mid-cycle will return a falsely elevated number that could be mistaken for ovarian insufficiency.

How FSH Changes Across Your Life

FSH levels change considerably from puberty through postmenopause. During the reproductive years, a day-2 or day-3 FSH under 10 mIU/mL is generally reassuring for ovarian reserve, though no single cut-off perfectly predicts response to stimulation. Research published in Fertility and Sterility has shown that the combination of FSH with antral follicle count and anti-Mullerian hormone (AMH) outperforms FSH alone for predicting ovarian response in IVF cycles.

In perimenopause, FSH begins to trend upward as fewer follicles remain and the ovaries produce less inhibin B (the hormone that normally dampens FSH secretion). By postmenopause, FSH is persistently elevated above 25 mIU/mL and often above 40 mIU/mL, because the feedback loop that would lower it is gone.

Normal FSH Ranges by Life Stage

There is no single "normal FSH." The reference range depends entirely on where you are in your cycle and in your reproductive life. The ranges below reflect Endocrine Society clinical guidelines and widely used laboratory reference intervals.

Reproductive Years (Cycle Day 2-3)

| Phase | Typical FSH Range | |---|---| | Early follicular (day 2-3, target draw) | 3.5 to 12.5 mIU/mL | | Mid-cycle (ovulatory surge) | 4.7 to 21.5 mIU/mL | | Luteal phase | 1.4 to 9.9 mIU/mL |

A day-3 FSH above 10 mIU/mL warrants attention. ASRM's committee opinion on ovarian reserve testing notes that while no single threshold definitively predicts poor response, values consistently above 10 mIU/mL are associated with reduced ovarian reserve and lower live-birth rates per IVF cycle.

Perimenopause

FSH in perimenopause is notoriously variable. A woman may have an FSH of 18 mIU/mL one cycle and 7 mIU/mL the next, because follicular activity is erratic rather than absent. The Menopause Society (formerly NAMS) states that a single elevated FSH cannot confirm perimenopause or menopause in a woman who is still having periods, even irregular ones. Diagnosis of perimenopause remains clinical, based on symptom pattern and menstrual history.

Menopause Confirmation

FSH above 40 mIU/mL on two separate draws, taken 4 to 6 weeks apart, in a woman who has not had a period for 12 or more months, is the biochemical threshold used to confirm menopause. The Endocrine Society's clinical practice guideline on menopause reserves this testing primarily for women under 45, for women on hormonal contraception where symptoms are ambiguous, or when premature ovarian insufficiency (POI) is being evaluated.

Postmenopause

After the final menstrual period, FSH stabilizes at persistently elevated levels, typically 25 to 135 mIU/mL, because ovarian estradiol and inhibin production has ceased. If a postmenopausal woman's FSH drops unexpectedly, that finding warrants investigation for an estrogen-secreting ovarian tumor or exogenous estrogen exposure.

When Should You Order an FSH Test?

Here is a practical framework for deciding when FSH adds clinical value, organized by the question you are actually trying to answer. Not every scenario calls for FSH, and ordering it at the wrong cycle day can be more misleading than helpful.

You Are Trying to Conceive and Want to Know Your Ovarian Reserve

Order FSH on cycle day 2 or 3. Pair it with estradiol (E2), because a day-3 estradiol above 60 to 80 pg/mL can suppress FSH artifactually, masking a truly elevated value. Also order AMH, which can be drawn on any day of the cycle and does not fluctuate the way FSH does. A 2023 systematic review in the Journal of Clinical Endocrinology and Metabolism confirmed that AMH has superior test characteristics for predicting poor ovarian response compared with day-3 FSH alone, though both markers together still do not reliably predict natural conception.

If your day-3 FSH is above 10 mIU/mL, repeat it the following cycle before making treatment decisions. FSH can vary cycle to cycle, and one elevated result does not necessarily mean your ovarian reserve is severely diminished.

Your Periods Have Become Irregular and You Want to Know if Perimenopause Has Started

For most women in their mid-40s, perimenopause is a clinical diagnosis. A single FSH value rarely changes management. Still, FSH testing is reasonable when:

• You are younger than 45 and want to rule out premature ovarian insufficiency.
• You are on combined hormonal contraception and cannot use cycle regularity as a guide.
• Your clinician needs biochemical data to support a decision about starting menopausal hormone therapy (MHT).

If FSH is ordered in this context, draw it during the hormone-free interval of your pill pack, or after at least two weeks off hormonal contraception, to get a meaningful result.

You Have Not Had a Period for 12 or More Months

This is the scenario where FSH is most diagnostically useful. Confirm menopause with two FSH draws above 40 mIU/mL, four to six weeks apart. For women under 45, ACOG Practice Bulletin guidance recommends confirming the FSH elevation and ruling out secondary causes of amenorrhea, including thyroid disease and hyperprolactinemia.

You Have Been Diagnosed with PCOS

In PCOS, FSH is often in the low-normal range, while LH tends to be disproportionately elevated, producing an LH:FSH ratio greater than 2:1 in some (though not all) women with PCOS. Rotterdam consensus criteria for PCOS do not require FSH for diagnosis, but FSH is useful when distinguishing PCOS from hypothalamic amenorrhea or from early POI, both of which can cause irregular cycles.

You Have a Suspected Pituitary Problem

Low or undetectable FSH in a woman of reproductive age with irregular or absent periods points toward hypothalamic or pituitary dysfunction rather than an ovarian problem. Common causes include hypothalamic amenorrhea (low energy availability, excessive exercise, stress), hyperprolactinemia, and hypopituitarism. In this scenario, FSH is part of a broader panel that should include LH, prolactin, TSH, and estradiol.

What Does a High FSH Mean?

Elevated FSH means the pituitary is working harder than usual to stimulate follicles. That extra effort typically signals one of two things: the ovaries have fewer or less-responsive follicles than expected for your age (diminished ovarian reserve or menopause), or there is primary ovarian insufficiency.

Diminished Ovarian Reserve

A persistently elevated day-3 FSH (above 10 mIU/mL across two or more cycles) in a woman of reproductive age suggests diminished ovarian reserve (DOR). The ASRM defines DOR as reduced quantity or quality of oocytes such that fertility potential is lower than expected for age. DOR does not mean you cannot conceive, but it does mean time may be a more pressing factor, and early referral to reproductive endocrinology is appropriate.

Premature Ovarian Insufficiency

FSH above 25 mIU/mL on two draws, four or more weeks apart, before age 40, meets the biochemical criteria for premature ovarian insufficiency (POI), formerly called premature menopause. ACOG Committee Opinion 698 emphasizes that POI is distinct from natural menopause in terms of etiology, cardiovascular risk, bone loss rate, and management. Women with POI require hormone replacement for bone and cardiovascular protection until at least the average age of natural menopause (51), regardless of whether they are having vasomotor symptoms.

Menopause

FSH above 40 mIU/mL in a woman who has been amenorrheic for 12 months or more confirms natural menopause. No further cycling or egg development is occurring.

What Does a Low FSH Mean?

Low FSH in a woman of reproductive age with absent or irregular periods is not reassuring. It points away from an ovarian cause and toward the hypothalamus or pituitary. FSH below 3 mIU/mL in this context warrants evaluation for:

• Hypothalamic amenorrhea. The most common cause in reproductive-age women, often linked to energy deficit, disordered eating, intense endurance training, or psychosocial stress. FSH and LH are both low to low-normal because GnRH pulsatility is suppressed. A landmark paper in the New England Journal of Medicine showed that hypothalamic amenorrhea is reversible with weight restoration and stress reduction in many women, with FSH and LH normalizing as GnRH pulsatility returns.
• Hyperprolactinemia. Elevated prolactin suppresses GnRH, which in turn lowers FSH and LH. Ordering prolactin alongside FSH catches this diagnosis.
• Hypopituitarism. Pituitary insufficiency from a tumor, trauma, or Sheehan syndrome (postpartum pituitary infarction) can reduce FSH secretion. Sheehan syndrome is a specifically female cause of low FSH that is often underdiagnosed.

In postmenopause, a low FSH is unexpected and requires the same investigation.

How to Lower a High FSH (and What Actually Works)

The phrase "how to lower FSH" is searched frequently, but the biology here needs honest framing. FSH is not a treatment target in isolation. It is a signal. Lowering FSH artificially without addressing the underlying issue does not improve fertility outcomes.

What the Evidence Supports

There is no well-powered randomized controlled trial demonstrating that any supplement or lifestyle change reliably lowers FSH and simultaneously improves live-birth rates in women with DOR. A 2019 Cochrane review on interventions for women with poor ovarian response found insufficient evidence to recommend any specific adjunct treatment (including DHEA, CoQ10, or growth hormone) over standard IVF protocols for improving live-birth rates.

That said:

• Reducing energy deficit in women with hypothalamic amenorrhea can normalize the hypothalamic-pituitary-ovarian axis, lowering FSH from the suppressed-but-variable state seen in HA back toward normal follicular-phase values.
• Estradiol priming before an IVF cycle is sometimes used by reproductive endocrinologists to suppress FSH before stimulation, but this is a procedural decision, not a self-directed supplement protocol.
• Avoiding exogenous androgens or anabolic steroids, which suppress the HPO axis and can paradoxically worsen FSH profiles over time.

What Lacks Evidence

Supplements marketed to "lower FSH" (myo-inositol, melatonin, DHEA, royal jelly, wheatgrass) are not supported by data from adequately powered trials for this specific outcome. Some (like myo-inositol) have evidence for improving egg quality markers in PCOS, but that is a different mechanism and a different population. Be skeptical of claims that tie supplement use to FSH normalization and improved fertility in a single step.

How FSH Interacts with Other Hormones Women Should Know

FSH does not work alone. Reading it alongside these markers gives a more complete picture.

| Hormone | Why It Matters with FSH | |---|---| | LH | The LH:FSH ratio helps distinguish PCOS (ratio >2:1) from hypothalamic amenorrhea or POI | | Estradiol (E2) | High E2 on day 3 can suppress FSH, masking true reserve; always pair with FSH | | AMH | Does not fluctuate with cycle day; reflects primordial follicle pool more directly | | Inhibin B | Falls before FSH rises in early perimenopause; low inhibin B with rising FSH = transition | | Prolactin | Elevated prolactin suppresses FSH; always rule out before diagnosing hypothalamic amenorrhea | | TSH | Hypothyroidism causes anovulation; thyroid disease is more common in women and can mimic FSH-related disorders |

FSH Across Specific Conditions Affecting Women

PCOS

Women with PCOS often have FSH in the low-to-normal range (3 to 8 mIU/mL) with a disproportionately elevated LH, reflecting chronic anovulation and excess LH pulsatility. A study in the Journal of Clinical Endocrinology and Metabolism found that the LH:FSH ratio was elevated in approximately 60% of women with PCOS, though this finding is neither sensitive nor specific enough to use as a diagnostic criterion on its own.

Endometriosis

Endometriosis does not directly alter FSH levels, but the ovarian damage caused by endometriomas can reduce the follicular pool and push FSH upward. Women who have had ovarian surgery for endometriomas are at higher risk of diminished ovarian reserve. If you have endometriosis and are thinking about fertility, requesting a day-3 FSH and AMH sooner rather than later gives you better information for timing decisions.

Premature Ovarian Insufficiency and Hormone Replacement

Women diagnosed with POI before 40 face a distinctly different risk profile than women entering natural menopause at 51. Bone loss in POI is rapid. Data from the European Society of Human Reproduction and Embryology (ESHRE) guideline on POI estimates that women with untreated POI lose bone density at a rate that substantially increases fracture risk by the fourth and fifth decades of life. Hormone replacement in POI is not optional for most women; it is medically indicated.

Thyroid Disease and Postpartum Thyroiditis

Postpartum thyroiditis affects an estimated 5 to 10% of women in the first postpartum year. The resulting thyroid dysfunction can cause menstrual irregularity and secondary changes in FSH through hypothalamic disruption. If you are postpartum with irregular cycles and an abnormal FSH, always check TSH before attributing the FSH change to ovarian reserve issues.

Pregnancy, Lactation, and Contraception Considerations

FSH in pregnancy. FSH falls to near-undetectable levels during pregnancy. The placenta produces human chorionic gonadotropin (hCG), which takes over the role of supporting the corpus luteum, and the feedback from rising estrogen and progesterone suppresses pituitary FSH secretion. Ordering FSH during pregnancy is not clinically useful and the result cannot be interpreted by standard reference ranges. If you are pregnant, FSH testing should not be on your panel.

FSH during lactation. Breastfeeding suppresses GnRH pulsatility through elevated prolactin, which secondarily suppresses FSH and LH. This is why many lactating women experience amenorrhea (lactational amenorrhea). FSH will be low and does not reflect underlying ovarian reserve during this period. If you are trying to assess your fertility after pregnancy, wait until regular cycles have resumed, or rely on AMH (which is less affected by lactational suppression) rather than FSH.

Contraception and FSH testing. Combined hormonal contraceptives (pills, patch, ring) suppress the HPO axis and will falsely lower FSH. Progestin-only methods have variable effects. If you need a meaningful FSH result for fertility or menopause evaluation, draw it after at least two weeks off combined hormonal contraception, or during the hormone-free interval of your current pack. Discuss timing with your clinician before stopping contraception solely for testing purposes.

Fertility preservation and FSH. For women considering egg freezing, a day-3 FSH combined with AMH and antral follicle count is the standard pre-stimulation workup. ASRM practice guidelines on oocyte cryopreservation state that ovarian reserve testing should be performed before any assisted reproductive technology cycle to counsel patients on expected response and adjust stimulation protocols accordingly.

Who This Test Is Right For (and Who Can Skip It)

Consider ordering FSH if you:

• Are trying to conceive and want to understand your ovarian reserve (order with AMH and E2, day 2-3).
• Are younger than 45 with irregular or absent periods and no clear explanation.
• Have not had a period for 12 months and want biochemical menopause confirmation (especially if considering MHT and under 50).
• Have a family history of early menopause or have had ovarian surgery or chemotherapy.
• Have symptoms suggesting POI (hot flashes, night sweats, vaginal dryness) before age 40.
• Have PCOS and your clinician wants to assess the LH:FSH ratio as part of a fuller hormonal picture.

You can likely skip FSH if you:

• Are perimenopausal (over 45) with irregular cycles and classic vasomotor symptoms. Perimenopause is a clinical diagnosis; FSH will not change your management.
• Are pregnant. The result is uninterpretable.
• Are exclusively breastfeeding and not yet having cycles. AMH is more informative.
• Have already confirmed menopause biochemically and are stable on MHT with no new symptoms.
• Are simply curious about your "hormone levels" without a specific clinical question. FSH alone, without clinical context, leads to more confusion than clarity.

Making Sense of Your FSH Result: A Practical Checklist

Before you panic or celebrate over a number, run through these questions with your clinician:

1. What cycle day was the blood drawn? If not day 2-3, the result may not reflect your true baseline.
2. Were you on hormonal contraception? Combined OCs suppress FSH and make results uninterpretable.
3. What was your estradiol on the same draw? A high E2 can mask an elevated FSH.
4. What is your AMH? One high FSH with a normal AMH and good antral follicle count tells a different story than high FSH with low AMH.
5. Has this FSH been repeated? One result is less reliable than two consistent results across cycles.
6. What is your clinical picture? Age, symptoms, menstrual history, and prior ovarian surgery all modify what the number means.

The Endocrine Society's guidelines on female hypogonadism state directly that "biochemical tests should be interpreted in the context of the clinical presentation and should not be used as the sole basis for diagnosis." That principle applies squarely to FSH.